论文部分内容阅读
目的探讨孟鲁司特钠对小儿咳嗽变异性哮喘治疗的临床效果分析。方法选择临颍县人民医院2013年7月至2015年1月收治的88例小儿咳嗽变异性哮喘患儿为研究对象,随机分为对照组44例实施常规治疗方案;观察组44例在常规治疗基础上加用孟鲁司特钠治疗,对两组患者治疗后临床效果进行对比分析。结果观察组治疗后总有效率为93.18%,明显较对照组(70.45%)高,差异有统计学意义(P<0.05);观察组咳嗽、咽喉肿痛、肺部鸣音等症状缓解时间明显较对照组短,差异具有统计学意义(P<0.05)。结论小儿咳嗽变异性哮喘采取孟鲁司特钠治疗的效果显著,可快速缓解症状,减轻患者身体负担,值得推广。
Objective To investigate the clinical effect of montelukast on children with cough variant asthma. Methods 88 children with cough variant asthma treated in Linying People’s Hospital from July 2013 to January 2015 were randomly divided into control group (44 cases) and conventional treatment group (44 cases) Based on the use of montelukast sodium treatment, the two groups of patients after treatment compared the clinical effect. Results The total effective rate in the observation group was 93.18%, which was significantly higher than that in the control group (70.45%), the difference was statistically significant (P <0.05). The relief time of cough, sore throat and lungs in the observation group was significantly longer Compared with the control group, the difference was statistically significant (P <0.05). Conclusion The effect of taking montelukast sodium in children with cough variant asthma is remarkable, which can relieve the symptoms quickly and reduce the body burden of patients, so it is worth to be popularized.